Академический Документы
Профессиональный Документы
Культура Документы
PERIODONTOLOGY 2000
Virtually all types of periodontal disease are caused by periodontal pocket infections, although several other factors, including trauma, aging, systemic diseases, genetics, etc., can contribute to the destruction of the periodontium (1, 18, 31, 52, 60, 107, 128, 127, 194). Repair of the periodontium and the regeneration of periodontal tissues remains a major goal in the treatment of periodontal disease and is an area still in need of major research attention, as recently stated by the American Academy of Periodontology (260). In general, to achieve complete tissue regeneration and repair, it is necessary to recapitulate the process of embryogenesis and morphogenesis involved in the original formation of the tissue. In the case of the periodontium, complete periodontal repair entails de novo cementogenesis, osteogenesis and the formation of periodontal ligament bers. Current strategies for periodontal repair are based on anti-infectious measures such as scaling and root planing, guided tissue regeneration (with or without bone grafts) or the use of growth factors, none of which fully restore the architecture of the original periodontium. Several different approaches involving tissue engineering are currently being explored to achieve complete, reliable and reproducible regeneration of the periodontium. As tissue engineering is dened as the science that develops techniques (based on principles of cell and developmental biology) for fabricating new tissues to replace or regenerate lost tissues (205), it is important to understand the formation of specic tissues, the physico-chemical characteristics of the tissues and the molecular events leading to the normal function of the tissues.
responsible for the attachment of teeth in the oral cavity (144). Several excellent reviews have been published describing the embryonic lineage of the principal periodontal tissues (cementum, periodontal ligament, gingiva and alveolar bone), as well as the cells and extracellular matrix components of the periodontium (10, 13, 14, 21, 19, 46, 45, 51, 71, 80, 82, 144, 158, 185, 186, 193, 212, 214, 243, 244, 245). Formation of the periodontium is initiated with the process of root formation where, following crown formation, the apical mesenchyme continues to proliferate to form the developing periodontium, while the inner and outer enamel epithelia fuse below the level of the cervical enamel to produce a bilayered epithelial sheath, termed the Hertwigs epithelial root sheath. As these cells divide, there is an apical migration of the Hertwigs epithelial root sheath cells through the underlying dental ectomesenchymal tissues, dividing them into the dental papilla and the dental follicle (Fig. 1). As the root develops, the rst radicular mantle dentin is formed and the epithelial sheath is fenestrated. It is believed that cells of the Hertwigs epithelial root sheath migrate away from the root into the region of the future periodontal ligament where they re-associate to form the Epithelial Rest of Malassez. However, not all Hertwigs epithelial root sheath cells migrate into the periodontal ligament site; a few undergo apoptosis and some remain in the root surface (108). Although it is accepted that the Hertwigs epithelial root sheath plays an important role in root development, the precise nature of its role remains controversial. In 1940, Schour & Massler suggested that the major function of the Hertwigs epithelial root sheath was to induce and regulate root formation, including the size, shape and number of roots (244). Other investigators suggested that the role of the Hertwigs epithelial root sheath was to induce the differentiation
196
Fig. 1. Root development and periodontium formation. Histological sections of 7-day postnatal mouse mandibular molars showing the initial development of the root by formation of the Hertwigs epithelial root sheath. At the 14-day postnatal time-point, apical migration of the roots
continues, and there is formation of the periodontium with cementum, periodontal ligament and bone. Am, ameloblasts; C, cementum; D, dentin; Ds, dental sac; HERS, Hertwigs epithelial root sheath; Od, odontoblasts; PDL, periodontal ligament.
of odontoblasts to form the root dentin (183, 182, 222, 243, 251), or to differentiate dental sac cells into cementoblasts (181). The current notion states that Hertwigs epithelial root sheath cells produce the basement membrane containing chemotactic proteins, which serve to direct the migration of precementoblast cells (140, 141, 182, 235, 251) and to induce cementoblast differentiation (191, 232, 234). Amongst the basement membrane molecules are several extracellular matrix proteins, growth factors, enamel proteins and adhesion molecules, such as a collagenous-like protein, known as cementum attachment protein (CAP), which has chemotactic potential capable of recruiting putative cementoblast precursors (11, 149, 156, 196, 275). In the second stage of cementogenesis (when the tooth reaches occlusion and cellular cementum is formed), the proliferation of cells of the Hertwigs epithelial root sheath is considerably reduced, and some cells are entrapped in the newly formed mineral where they may inuence phenotypic changes in the dental sac cells (252). It is also suggested that Hertwigs epithelial root sheath cells undergo epithelialmesen-
chymal transformation to become functional cementoblasts in charge of producing the acellular cementum (251, 275). The gingival tissues appear to be derived from both the oral mucosa and the developing tooth germ (135). It has been suggested that the dental follicle (connective tissue surrounding the developing teeth) gives rise to the broblasts forming the periodontal ligament as well as to the alveolar bone and cementoblasts (45, 136, 186, 243), all of which have a common neural crest origin (34). Therefore, it is postulated that there are different types of cementoblasts: those originating from the Hertwigs epithelial root sheath via epithelialmesenchymal transformation and which form the acellular cementum; and those derived from the dental follicle, which form the cellular cementum (9, 19, 105, 251, 275). It is also believed that progenitors for periodontal ligament, osteoblast and cementoblast cells adopt a paravascular location in the periodontal ligament, and these cells, which exhibit some features of stem cells, can regenerate functional tissues when the need arises (150153, 195). Periodontal
197
Zeichner-David
ligament stem cells have recently been isolated from the human periodontium (162, 224, 225). The Epithelial Rest of Malassez cells remain in the periodontal ligament throughout life, suggesting that they have important, although yet unknown, functions, rather than just being leftover structures. Roles attributed to the Epithelial Rest of Malassez cells range from bad to good. The Epithelial Rest of Malassez cells are held responsible for the formation of periodontal cysts and tumors as a result of periapical inammation associated with pulpal necrosis (26, 57, 77, 176, 226, 242). It has also been suggested that Epithelial Rest of Malassez cells contribute to the formation of the periodontal pocket because of their continuum with the junctional epithelium (176, 238). Some studies report the ability of Epithelial Rest of Malassez cells to resorb bone and extracellular matrix, and thus implicate the cells in root resorption (15, 75, 122). On the other hand, it has also been suggested that the cells of the Epithelial Rest of Malassez may protect the root from resorption (259). The nding of Epithelial Rest of Malassez cells being closely associated with neural endings suggests that they have a role in the development of periodontal ligament innervation (126). Studies performed with 1-hydroxyethylidene-1,1-bisphosphonate, a drug that interferes with homeostasis in the periodontal ligament, showed a severe reduction in the width of the periodontal ligament with the development of ankylosis, which was repaired after discontinuing the administration of 1-hydroxyethylidene-1,1-bisphosphonate (261). As the study did not detect a change in the number of Epithelial Rest of Malassez cells posttreatment, it was suggested that cells of the Epithelial Rest of Malassez are unlikely to play an important part in the homeostasis of, and may not be a prerequisite for, the repair and maintenance of the periodontal ligament. On the other hand, the Epithelial Rest of Malassez cells secrete hyaluronic acid, which contributes to the formation of the loose connective tissue characteristics of the periodontal ligament (155). Cells of the Epithelial Rest of Malassez react to mechanical stress, like that associated with orthodontic tooth movement, by increasing their proliferation rate and cell size (27), and thereby help to maintain the space between the periodontal bone and cementum to avoid ankylosis (134). The increased activity of the Epithelial Rest of Malassez cells is consistent with their putative role on collagen turnover in the periodontal ligament, which is accelerated during tooth movement (241), and during cementum repair in areas of root resorption (24). It is suggested that the Epithelial Rest of Malassez cells
may negatively regulate root resorption and induce acellular cementum formation (56). In addition, cells of the Epithelial Rest of Malassez may help in cementum repair because of their ability to activate matrix proteins, such as amelogenin, which are also expressed during tooth development (76, 81). In summary, based on the information presented, it appears that the developed or adult periodontium retains its potential for repair/regeneration in the form of cells of the Epithelial Rest of Malassez, progenitor cells and stem cells, which can be induced to differentiate into cementoblast, osteoblast or periodontal ligament cells to regenerate periodontal tissues.
198
information as to the function of these growth factors in periodontium development. Furthermore, the transforming growth factor-b1-knockout mouse displays no apparent defects in tooth and root development (39), thus excluding a role for this factor in these processes. On the other hand, by using transgenic mice that express the BMP inhibitor, noggin, driven by the keratin 14 promoter (K14-noggin), we recently demonstrated that BMPs are important for proper root morphogenesis. When the function of BMPs is repressed, the transgenic mice demonstrate a delay in tooth development, lack of enamel formation and abnormally shaped roots (198). Insulin-like growth factor-I receptor has been demonstrated in the Hertwigs epithelial root sheath, and in vitro experiments suggest that insulin-like growth factor-I receptor plays a role in the proliferation and elongation of the Hertwigs epithelial root sheath, which is critical for root development (55). Transcription factors associated with root development include two members of the homeobox family of transcription factors: Dlx2 and Dlx3. The expression of Dlx2 by the Hertwigs epithelial root sheath during root development was demonstrated using Dlx2/LacZ transgenic mice (132). Although these studies are only suggestive of a role of Dlx2 in root development, it was of interest that the Dlx2 knockout mice showed normal teeth, while the Dlx1/Dlx2 knockout mice lacked maxillary molars (253). The involvement of Dlx3 in root development comes from the phenotype expressed by patients affected with the genetic disease, trichodento-osseous syndrome, which presents root defects as well as defects in hair, bone and enamel. A deletion of 4 bp in the Dlx3 gene, which causes a frameshift mutation and premature codon termination, resulting in an altered protein, were identied in a family with tricho-dento-osseous syndrome (199). We recently reported the importance of the N-c transcription factor in root development. N-c knockout mice appear normal, except that they exfoliate their teeth shortly after eruption. These mice show a lack of roots of both mandibular and maxillary teeth, and therefore their teeth have no bone attachment. Histological analysis indicated a normal crown, enamel and dentin formation, and although there is initial formation of the Hertwigs epithelial root sheath and a budding root, no further development occurs of the roots, cementum and periodontal attachment apparatus (239).
Cementum composition
In order to understand the process of cementogenesis, it is important to determine the composition of
cementum. As in bone and dentin, the major component of cementum is collagen (16). The expression of noncollagenous proteins that stimulate cell migration, attachment, proliferation, protein synthesis and mineralization during root formation has been reported by several investigators (38, 142, 147). In the early stages of root development, immunohistochemical techniques have shown the expression of multifunctional proteins, such as laminin and bronectin (140). These proteins, as well as other proteins extracted from cementum (173), are initially believed to function as chemo-attractants. Laminin and bronectin can also function as adhesion proteins, together with tenascin (137), bone sialoprotein (38, 142), osteopontin (25), and a 55-kDa cementumattachment protein (196, 263). The presence of other bioactive proteins, such as enamel-like proteins (235, 234), osteonectin/SPARC (201), and mitogenic factors (157, 269), have also been reported in the cementum. In addition to these proteins, cementoblasts synthesize and secrete several glycosaminoglycans (such as chondroitin-4-sulfate, chondroitin-6-sulfate and dermatan sulfate, and collagen brils), which are present in the cementodentinal junction (88, 264, 265). It has been suggested that cementoblasts exhibit an osteoblast-like, rather than an odontoblastlike, phenotype (25). Odontoblast, osteoblast and cementoblast cells express several matrix proteins, such as osteopontin, bone sialoprotein (BSP), osteonectin, osteocalcin, matrix Gla protein (208) and dentin-matrix-protein 1 (DMP-1) (106). The presence of osteocalcin in cementum is more controversial. Bronckers et al. (25), using immunohistochemistry, reported the presence of osteocalcin on the cellular intrinsic ber cementum (CIFC) and associated cementoblasts (mature), but not in the acellular cementum and its associated cementoblasts. Tenorio et al. (246) reported the presence of osteocalcin in acellular extrinsic ber cementum (AEFC) but not in the associated cementoblasts, while CIFC and associated cementoblasts stained weakly. Bosshardt & Nanci (20) used two different antibodies (OC1 and OC2), which gave different results: OC1 showed reactivity with acellular cementum, while OC2 was negative. Similarly, the presence of DMP-1 has been associated with acellular cementum (275) and cementocytes, but not with cementoblasts (255). It has been suggested that acellular cementum is a unique tissue, while cellular cementum and bone share some similarities, although there are still morphological, functional and biochemical differences between the two tissues (19). The presence of cementum-specic proteins remains questionable, although some putative
199
Zeichner-David
cementum-specic proteins have been invoked: a 55-kDa CAP (263); a mitogenic factor (167); and a 72-kDa protein, CEM-1 (235). However, as the characterization and the sole expression by cementoblasts of these proteins have not been determined, the possible existence of cementum-specic proteins remains unknown. It has been reported that cementoblasts and cementocytes produce high levels of the GLUT-1 monosaccharide transporter, while osteoblasts or osteocytes do not express this protein. These data suggest that GLUT-1 may play a role in cementogenesis and could serve as a biomarker to differentiate between cells of cementoblastic and osteoblastic lineage (124). However, the observed differences in GLUT-1 are quantitative, and GLUT-1 is present in many different cell types. Recently, we reported the isolation of a cementoblastoma-derived protein, CP-23, that is expressed by cementoblasts and some precursor cells present in the periodontal ligament, but not by osteoblasts. The function of the CP-23 protein is currently unknown; however, given its nuclear location, it may be required for cementoblast differentiation and may be used as a marker for cementoblast cells (3). The CP-23 protein is also expressed by Hertwigs epithelial root sheath cells (275). Based on our current knowledge of the development of periodontal tissues, several strategies exist for targeting regenerative therapy, ranging from inducing their own regenerative mechanisms using molecular approaches, or utilizing cells to repopulate and recapitulate the developmental process.
periodontal ligament cells are removed from the cementum or are unable to regenerate, bone tissue invades the periodontal ligament space and establishes a direct connection between the tooth and the wall of the alveolar socket, resulting in ankylosis. The ankylotic, nonexible type of tooth support can lead to loss of function and resorption of the tooth root (13).
200
deposition of acellular cementum on the root surface and formation of connective tissue. The second phase comprises a remodeling process, which will result in a regenerated cementum similar to pristine cementum as maturation proceeds over time (69). In conclusion, several clinical studies have demonstrated that guided tissue regeneration is a successful treatment modality for periodontal reconstructive surgery and it has become an accepted procedure in most periodontal practices, either by itself or in combination with other treatment modalities. Autologous bone grafts to repair periodontal osseous defects have been used for many years and different approaches have been the subject of several reviews (165, 209). Bone repair can also be achieved using ceramic materials such as Bioglass, which is a bone-bonding bioactive material that has been widely used for bone healing (110). Studies in monkeys suggested that PerioGlas (synthetic bone particulate) can achieve superior bone repair and cementum regeneration and retard epithelial down-growth compared with other, similar materials (50, 109). Additionally, these materials can be used as scaffolds or to deliver other bioactive molecules to enhance their function. The use of bone grafts, powders or ceramics is quite prevalent in many dental practices. A recent systematic review on the efcacy of bone replacement grafts compared with other interventions in the treatment of periodontal osseous defects was performed by Reynolds et al. (202). Meta-analysis indicated that for the treatment of intrabony defects, bone grafts are effective in reducing crestal bone loss, increasing bone level, increasing clinical attachment level, and reducing probing depth compared with open ap debridement procedures. Histological studies showed that demineralized freeze-dried bone allografts support the formation of a new attachment apparatus in intrabony defects; however, the available data indicate that alloplastic grafts support periodontal repair rather than regeneration, and that the best treatment is a combination of bone grafts with barrier membranes. Nevertheless, these strategies are directed mainly to enhance alveolar bone and periodontal ligament repair and have the problems that they do not address cementogenesis and therefore do not completely regenerate the architecture of the original periodontium.
regulate tooth development and tissue repair, suggests the use of some of these factors for periodontium regeneration (37, 61, 68, 71, 118, 116, 117, 128, 170). Some attachment proteins, such as bronectin (29, 206, 262) or CAP (156, 196), are able to enhance broblast migration, attachment and orientation of the connective tissue to the root surface. New strategies, utilizing growth factors to induce cell migration, proliferation and differentiation, were developed to repopulate the damaged periodontal tissues with periodontal ligament cells (32, 247). It is believed that growth factors play important roles in modulating the proliferation and/or migration and/ or differentiation of structural cells in the periodontium (58, 86, 97, 197, 230). It is suggested that growth factor molecules are produced during cementum formation and then stored in the mature cementum matrix with the potential to induce periodontal repair or regeneration when needed (236). Large-scale production of recombinant growth factors has facilitated in vitro and in vivo studies to determine the efcacy of growth factors in periodontal tissue regeneration. Amongst the growth factors currently being used are platelet-derived growth factor, insulin-like growth factor (36, 63, 92, 138, 188, 210), transforming growth factor-b1 (146), basic broblast growth factor (213), dexamethasone (211) and BMPs (121, 205, 211). However, problems in applying these growth factors for periodontal repair include the nonspecic activity of some factors on different cell lineages in time and space, and the rapid loss of growth factors applied topically (13, 138). It has been shown that both platelet-derived growth factor and insulin-like growth factor-1 can stimulate the proliferation and chemotaxis of periodontal ligament cells, and that the combination of platelet-derived growth factor and insulin-like growth factor-1 can further increase the mitogenic effect (23, 44, 175). In addition to the mitogenic activity, platelet-derived growth factor also appears to stimulate collagen synthesis in periodontal ligament cells (146). Furthermore, dexamethasone has been shown to exert the same effect as insulin-like growth factor-1 on periodontal ligament broblasts, gingival broblasts and pulp broblasts, and may substitute for insulin-like growth factor-1 in the platelet-derived growth factor stimulation of cell proliferation (210). In addition to the previously described effects, platelet-derived growth factor has the capacity to signicantly negate and reverse the inhibitory effects of lipopolysaccharide on the proliferation of human gingival broblasts. Lipopolysaccharide from a variety of gram-negative bacteria is known to inhibit
201
Zeichner-David
gingival broblast proliferation and synthesizing activity, has been implicated in periodontal inammation and may also be responsible for delayed wound healing following periodontal therapy (12). In vivo studies using the beagle dog (natural periodontal disease) and the nonhuman primate (ligatureinduced attachment loss) models showed that the application of platelet-derived growth factor/insulinlike growth factor-1 resulted in signicant amounts of new bone and cementum formation (138, 210). Treatment with insulin-like growth factor-1 alone did not signicantly alter healing compared with controls, while treatment with platelet-derived growth factor alone showed signicant regeneration of attachment. Although there are differences in the response to platelet-derived growth factor/insulin-like growth factor-1, depending on which animal model is used (the osseous response in dogs appears to be greater than that of the nonhuman primate, while new attachment formation appears to be greater in the nonhuman primate than in the dog), there is consistency in promoting periodontal regeneration (63, 64). Rutherford et al. (211) showed that platelet-derived growth factor and dexamethasone, combined with a collagen carrier matrix, induced regeneration of the periodontium in monkeys. It has also been shown that the combination of platelet-derived growth factor and guided tissue regeneration work better than either of the two modalities alone (36, 188). Clinical trials in humans using platelet-derived growth factor/insulin-like growth factor to treat periodontal osseous defects showed that only high doses of these factors gave rise to a statistically signicant increase in alveolar bone formation (92). When platelet-derived growth factor was used in combination with bone allografts to treat Class II furcations and interproximal intrabony defects, histological evaluation showed regeneration of new alveolar bone, cementum, and periodontal ligament (30, 171). Platelet-rich plasma is a fraction of plasma that contains platelet-derived growth factor and transforming growth factor-b (180). An alternative to the use of recombinant growth factors is the use of a platelet gel in combination with demineralized freeze-dried bone allografts (5, 43). The limitations of topical protein delivery to periodontal osseous defects include transient biological activity and bioavailability of platelet-derived growth factor at the wound site. To overcome these limitations, studies have used genetic engineering to transduce cells derived from the periodontium, using adenovirus carrying the platelet-derived growth factor gene to promote sustained release and ensure
biological activity (7, 6, 65). The potential use of gene therapy in vivo to stimulate periodontal tissue regeneration has been studied in large tooth-associated alveolar bony defects in rats. The results showed that the direct gene transfer of platelet-derived growth factor-B stimulates the regeneration of alveolar bone and cementum (104). As stated above, some members of the BMPs are normally expressed during the development of the periodontium, such as BMP-3 and BMP-7/OP-1, which have been localized immunologically in alveolar bone, cementum, and periodontal ligament, whereas BMP-2 was only localized in the alveolar bone (249, 266). Although the exact role of BMPs in the development of the periodontium has not yet been determined, these proteins are good candidates for stimulating periodontal regeneration because of their ability to promote not only osteogenesis but also cementogenesis. The expected role of BMPs in stimulating intramembranous bone formation without an endochondral intermediate may provide greater osteogenic potential than autogenous bone or other bone substitutes (121, 118, 119, 170, 205, 240). Studies indicate that recombinant BMP-2 exerts no effect on the growth and differentiation of human periodontal ligament cells in vitro; however, BMP-2 stimulates alkaline phosphatase activity and parathyroid hormone-dependent 3,5-cyclic adenosine monophosphate (cAMP) accumulation, which are early markers of osteoblast differentiation. Nevertheless, BMP-2 produced no mature osteoblasts, as measured by expression of osteocalcin, and also inhibited 1,25(OH)2D3-induced osteocalcin synthesis in these cells (123). In vitro studies using mouse-derived dental follicle and periodontal ligament cells suggest that BMP-2 induced dental follicle cells to differentiate towards a cementoblast/osteoblast phenotype but had no effect on periodontal ligament cells (278). Paradoxally, BMP-2 was found to inhibit cementoblast cell mineralization in vitro by decreasing the expression of BSP and collagen type 1 (279). In studies of BMP-2 on early wound healing in a rat model of periodontal regeneration, the connective tissue attachment was found to be similar in animals receiving BMP-2 and in controls. However, BMP-2 induced bone formation at some distance from the defect, which indicates the need for a suitable delivery system to maintain the BMP-2 at the site of implantation (120). Other studies suggest that the effects of BMPs may be inuenced by certain factors, such as root surface conditioning, delivery systems, masticatory forces, etc., and that BMP-2 stimulates the proliferation and migration of cells from the adjacent
202
periodontal ligament into the wounded area, promoting new cementum formation (119). The expression of both BMP-2 and BMP-7 during periodontal tissue morphogenesis suggests that optimal therapeutic regeneration may require the combined use of the two BMPs. BMP-7-treated molar furcation defects in baboons resulted in substantial cementogenesis, while BMP-2 showed limited cementum formation but greater amounts of mineralized bone and osteoid; however, the combined application did not enhance alveolar bone regeneration or new attachment formation over and above that obtained by separate applications of the two BMPs (207). Recently, it was shown that the application of a synthetic BMP-6 polypeptide to a periodontal fenestration defect in rats resulted in increased formation of new bone and cementum (93). Perhaps the use of other members of the BMP family, such as growth and differentiation factor-5, )6, and )7, might provide better and more complete regenerative outcomes. These factors have been detected during the process of periodontal development at the surfaces of alveolar bone, cementum and periodontal ligament ber bundles (223). Limitations for the regular use of BMPs are the need for high doses, non-specic activity on different cell lineages in time and space, and the rapid loss of topically applied growth factors (13, 138). Some of these problems can be overcome by the use of gene transfer technology. Jin et al. (103) used adenoviruses containing BMP-7 to transduce dermal broblasts that were then used to treat mandibular alveolar bone defects in a rat wound repair model. Their results showed chrondrogenesis, with subsequent osteogenesis, cementogenesis and bridging of the periodontal bone defects, suggesting that this genetic engineering approach may be useful in alveolar bone regeneration. A recent literature review (62) concluded that although promising, there were insufcient data at the present time to conduct a meta-analysis on the effect of growth factors for periodontal repair, and pointed to the need for more clinical trials.
keys, followed by histological analysis that showed almost complete regeneration of acellular cementum, rmly attached to the dentin and with collagenous bers extending towards newly formed alveolar bone (79). These studies resulted in a new therapeutic preparation to treat periodontal disease, consisting of hydrophobic enamel matrix proteins extracted from porcine developing enamel, which has been marketed by Biora, Inc., under the name of Emdogain. In the past 8 years, the use of enamel proteins for inducing the formation of cementum, bone and dentin has generated numerous in vivo and in vitro studies, as well as clinical trials, resulting in almost 300 publications. In vitro studies, animal studies and clinical trials are all being conducted simultaneously (60, 70, 83, 154). In vitro studies, using periodontal-associated cells such as periodontal ligament broblasts, osteoblasts, cementoblasts, gingival broblasts, gingival epithelial cells, etc., have been conducted in an attempt to understand the molecular and cellular mechanisms involved in the process of enamel matrix derivativeinduced tissue regeneration. In order for enamel matrix derivative to regenerate periodontal tissues, it will need to exert an effect on proliferation, migration, attachment and/or differentiation of the surrounding periodontal cells, and most studies have measured these parameters, as shown in Table 1. Few studies have tested the effect of enamel matrix derivative on cell migration, but available data suggest an increased migration of periodontal ligament cells, osteoblasts, gingival broblasts and dermal broblasts in response to enamel matrix derivative, with the exception of one study that found no effect on periodontal ligament cells (184). Most studies on the effect of enamel matrix derivative on cell attachment, which generally included periodontal ligament cells, found an increase in cell attachment (184). However, one study found the enamel matrix derivative to have no effect on cell attachment of gingival broblasts (256). A number of studies, which measured the effect of enamel matrix derivative on cell proliferation, have found an increase in cell proliferation in the presence of enamel matrix derivative. However, the proliferative effect was not found in two studies using periodontal ligament cells (41, 256), in two studies using osteoblast cell lines (215, 268) and in one study using gingival broblasts (256). Several studies found an inhibition of cell proliferation when epithelial cells were used (112, 139, 273). These data may explain the clinical observation that application of enamel matrix derivative suppresses the down-growth of junctional
203
204
Migration Attachment Proliferation ND No effect ND ND Yes ND ND ND ND Yes ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND Yes increase No effect Yes increase Yes increase ND Yes increase Yes increase Yes Yes increase Yes Yes increase Yes Yes increase Yes Yes increase ND Yes increase ND Increase cAMP, TGF-b1, IL-6, PDGF-AB Increase OPN Inhibits Col I, de novo expression BSP and OCN, increase BMP2 Inhibits Col I, de novo OCN and BMP3 BSP increase Yes No effect Increase AP and TGF-b1 ND ND ND Yes increase Yes, increase IGF-1 and TGF-b1. No effect on bone phenotype Increase matrix (versican, biglycan, decorin, hyaluronan Yes No difference ND ND Yes increase ND ND Yes increase Yes less AP cementoblast ND ND ND ND ND ND ND ND ND ND ND ND More FGF2 and COX2; less AP and MMP1 ND Yes AP Yes AP, Col, OPN, TGF-b1, OCN and MMPS ND Increase Col, IL-6 and PGHS-2; no effect on OCN and IGF-1 Increase OPN and less OCN No effect Yes decrease Yes, increase AP, OCN, TGB1 ND ND ND Yes- more ND ND ND Yes decrease No Col, AP No effect Yes increase No (Type I col) ND ND ND AP increase osteoblast Yes Differentiation (166) (184) (95) (33) (203) (41) (178) (73) (256) (89) (139) (204) (273) (273) (227) (161) (268) (268) (101) (102) (254) (215) (215)
Cells
Species
Zeichner-David
Human
Rat (primary)
Human (primary)
Human (primary)
Human (primary)
Human (primary)
Hu (primary)
Hu (primary)
Hu (primary)
Hu (primary)
P (primary)
Mo (cell line)**
Mo (cell line)
Osteoblasts
Hu (ROS17/2.8)
Hu (primary)
Mo (ST2)
Mo (KUSA/A1)
Mo (primary)
Mo (primary)
Mo (MC3T3-E1)
Hu (2T9 pre-osteoblasts)
Table 1. Continued
Migration ND Yes ND ND ND Yes ND ND Yes ND ND ND ND ND ND
Cells ND ND Yes ND ND ND ND No effect ND ND ND Yes ND ND ND ND ND ND No difference No effect ND Yes increase Increase OPN Yes increase More OPN, Less OCN Yes increase Decrease Ocn Decrease BSP Decrease OCN, increase OPN and OPG ND Yes vascular endothelium. Growth factors Yes ND ND ND ND ND Yes ND ND ND Yes increase ND ND Inhibited Inhibited Yes increase AP. Osteoblast phenotype Increase cAMP and PDGF-AB Increase p21WAF1/cip1; decrease CK-18 Yes increase Increase OPN No effect ND ND ND ND ND ND ND No difference ND Yes increase More ECM Yes increase ND No effect Increase AP and TGF-b1 ND Increase matrix (versican, biglycan, decorin, hyaluronan Yes increase ND Yes double Faster osteogenic ND BSP increase ND Yes more ND ND ND ND No ND ND Inhibits Inhibits Inhibits Inhibits ND Yes increase Increase OPN ND Yes increase ND ND Yes increase Yes, increase AP, OCN, TGB1 ND (215) (89) (204) (228) (115) (203) (73) (256) (89) (115) (72) (204) (74) (254) (258) (17) (72) (160) (203) (177) (113)
Species
Attachment Proliferation
Differentiation
Mineralization Reference
Hu (primary)
Hu (MG63)
P (primary)
Hu (Ros17/28)*
Rat
Hu (primary)
Hu (primary)
Hu (primary)
Hu (primary)
Rat
Rat
P (primary)
Dental follicle
Mo (SV40)
Cementoblasts
Mo (SV40)
Mo (OCCM-30)*
Mo (OCCM-30)ND
Fibroblasts
Mo (L929)
Rabbit
Human (primary)
Epithelial cells
Hu (HELA)
Hu (SCC25)
ERM
P (primary)
Endothelial cells
Hu (HUVEC)
Yes increase ND
AP, alkaline phosphatase; BMP, bone matrix protein; BSP, bone sialoprotein; Col, collagen; Hu, human; IGF-1, insulin-like growth factor; IL-6, interleukin-6; MMPS, matrix metalloproteinases; Mo, mouse; ND, not determined; OCN, osteocalcin; OPN, osteopontin; OPG, osteoprotegerin; P, pig; PDGF-AB, platelet derived growth factor AB; PGHS-2, prostaglandin G/H synthase 2; TGF-b1, transforming growth factor b-1. *Mouse recombinant amelogenin. Mouse recombinant ameloblastin. Mouse leucine rich amelogenin peptide (LRAP).
205
Zeichner-David
epithelium onto dental root surfaces, a process that frequently interferes with the formation of new connective tissue attachments (79, 78). The majority of available in vitro studies have analyzed the effect of enamel matrix derivative on gene expression and differentiation, and most of these studies found either an increased or a decreased expression of certain transcription and growth factors, extracellular matrix proteins or mineralization-associated proteins in the cells tested. Where mineralization was measured, it was found that enamel matrix derivative induced mineralization of periodontal ligament cells (166), increased mineralization of osteoblasts (268) and gingival broblasts (115), decreased mineralization of cementoblast cells (254) and inhibited the mineralization of dental follicle cells (74). Differences in results amongst studies can be explained by differences in sources and concentrations of enamel matrix derivative and in the cell preparations used. Most studies employed primary cell cultures derived from different patients, which probably contained mixed populations of a variety of cells present in the periodontium. Nevertheless, taken together, these studies suggest that enamel matrix derivative can act as a multipurpose growth factor capable of stimulating the proliferation of mesenchymal cells while inhibiting the cell division of epithelial cells, and can stimulate attachment and phenotypical changes in some cells, while inhibiting matrix production in others. Given the widespread use of Emdogain, and the fact that it is made from an extract of enamel proteins, it is important to identify the actual protein responsible for its function. Studies by Maycock et al. (148) found that, in addition to amelogenin, Emdogain contains metalloproteases and serine proteases. Studies by Kawase et al. (114) demonstrated that porcine enamel matrix derivative contains transforming growth factor-b1 (or a transforming growth factor-b-like substance), and that the action of enamel matrix derivative is mediated by the smad2 signaling pathway. In addition, a neutralizing anti-transforming growth factor-b immunoglobulin blocked the action of enamel matrix derivative on epithelial cells, although it failed to block completely enamel matrix derivative-induced broblastic proliferation, suggesting the presence of more than one growth factor. Iwata et al. (98) isolated the inductive activity of enamel matrix derivative by using chromatography and characterized it as being BMP-2 and BMP-4 using specic antibodies. Furthermore, in the presence of noggin (an inhibitor of BMPs), enamel matrix derivative lost its inductive activity, indicating
that BMPs are the molecules responsible for enamel matrix derivative activity. Although these studies suggest that the action of Emdogain is a result of the presence of contaminating growth factors, other studies have shown that pure recombinant enamel proteins indeed have activity as inducers. The results obtained in our laboratory indicate that mouse recombinant amelogenin can increase attachment and proliferation of mouse periodontal ligament cells in vitro (272, 273). Furthermore, a post-translational modied recombinant ameloblastin, another enamelassociated protein, had an effect similar to that of amelogenin on periodontal ligament cells. Both recombinant amelogenin and ameloblastin can change the phenotype expressed by periodontal ligament cells by inhibiting the expression of collagen type I and inducing de novo expression of osteocalcin. Amelogenin also induced the expression of bone sialoprotein and BMP-2, while ameloblastin induced the de novo expression of BMP-3 (273). These results indicate that both enamel-associated proteins have a modulatory effect on the expression of BMPs, suggesting that perhaps these proteins exert their signaling effect by means of BMPs. Recombinant mouse amelogenin improved osteoblast adhesion (90), and increased the expression of bone sialoprotein and decreased the formation of mineralized nodules in cementoblasts (258). A leucine-rich amelogenin peptide, which exhibited no effect on cell proliferation, down-regulated osteocalcin and up-regulated osteopontin in a dose- and timedependent manner, and inhibited the capacity to form mineral nodules (17). Taken together, these reports point towards a growth factor activity for enamel proteins that may be of importance in periodontal tissue regeneration. Several clinical trials have shown an increase in periodontal attachment and bone formation in individuals treated with Emdogain (54, 85, 87, 154, 179, 200, 217, 216, 218, 219, 277). However, in many of these studies, the results were no better than those obtained with other previously established treatments, such as guided tissue regeneration, which yields better outcomes in the management of deep intrabony periodontal defects (84, 187, 218, 221, 231). Histological studies revealed that treatment with Emdogain is unpredictable, resulting in the formation of cellular cementum rather than acellular cementum, and this cementum was only partially attached to the root surface, similar to the cementum formed with the use of guided tissue regeneration. Furthermore, more bone regeneration occurred by using a guided tissue regeneration procedure than
206
Emdogain (216, 219, 218). Other studies showed no evidence of improvement in radiographic bone level, and surgical re-entry found new tissue with a rubbery consistency and that was not mineralized (189, 190). Experiments in rats, using a wounded rat periodontium model followed by immunohistochemical analysis, showed that Emdogain does not affect the expression of differentiation markers or bone matrix protein synthesis in the repopulation response of wounded rat molar periodontium (35). Systematic studies, using literature reviews and meta-analysis, suggest that treatment with enamel matrix derivative results in signicant variations in clinical outcomes (107). Although Emdogain is able to signicantly improve probing attachment levels and pocket depth reduction, some studies found no evidence of clinically important differences between guided tissue regeneration and Emdogain (47, 62) and reported that guided tissue regeneration is more predictable for cementum and bone regeneration (257). Although animal histological studies with surgically created defects suggest that enamel matrix derivative induces the formation of acellular cemen-
tum and promotes attachment of the supporting periodontal tissues, human histological studies have questioned both the consistency of the histological outcomes and the ability of enamel matrix derivative to predictably stimulate the formation of acellular cementum (107). It appears that following treatment with enamel matrix derivative, a bone-like tissue resembling cellular intrinsic brous cementum is formed (22). Despite the mixed results obtained from both in vitro and in vivo studies, new applications of Emdogain are continuously being reported. Some studies suggest that it has the ability to induce the formation of reparative dentin in pulpotomized teeth (94, 96, 168, 169). It is being used to coat titanium implants with mixed results; one study suggests that there is enhanced formation of trabecular bone (229) while the other found no effect (53). It has also been suggested that enamel matrix derivative can combat bacteria in postsurgical periodontal wounds, which otherwise could hamper wound healing and reduce the outcome of regenerative procedures (8, 172, 220, 237). More recently, an acceleration of skin wound
PLF
Control 14 days HERS-CM Control
PL-7
HERS-CM Control
DPM
HERS-CM
21 days
28 days
35 days
Fig. 2. Effect of Hertwigs epithelial root sheath-conditioned media (HERS-CM) on periodontium-associated cell mineralization. HERS-CM was prepared by growing the cells in Dulbeccos modied Eagles minimal essential medium (DMEM) supplemented with 10% fetal calf serum (FCS) and 100 U/ml of penicillin/streptomycin. Cells were incubated at 39.5C in a humidied atmosphere of 95% air and 5% CO2 for 7 days, after which the media were collected, the protein concentration determined and then lyophilized. Periodontal ligament broblasts (PLF), ce-
mentoblasts (PL-7) and dental papillae mesenchyme broblasts (DPM) were prepared from Immortomouse (275). Cells were grown in differentiation conditions (DMEM supplemented with 10% FCS, 100 U/ml of penicillin/streptomycin, 50 mg/ml of ascorbic acid and 2 mM sodium b-glycerophosphate), with or without (controls) 100 lg of HERS-CM proteins. At different time-points of culture, cells were xed with 70% methanol and 30% acetic acid and stained with Von Kossa to determine mineralization.
207
Zeichner-David
the Epithelial Rest of Malassez cells, we are exploring the ability of these cells, or their secreted products, to induce periodontal ligament cells to differentiate into cementoblasts in vitro. When periodontal ligament cells, which do not produce a mineralized extracellular matrix, are grown in the presence of Hertwigs epithelial root sheath conditioned media (HERS-CM), these cells produce a mineralized extracellular matrix, as determined by a positive Von-Kossa staining
Effect of HERS-CM on PLF cell differentiation P BSP 21d 21d + HERS
OCN
OSN
OPN
AP
BMP4
Col1
Actin
Fig. 3. Effect of Hertwigs epithelial root sheath-conditioned media (HERS-CM) on the phenotype of periodontal ligament cells. HERS-CM was prepared as previously described. Periodontal ligament cells were grown under proliferation (P) conditions (in the presence of interferonc at 33C) or differentiation conditions [Dulbeccos modied Eagles minimal essential medium (DMEM) supplemented with 10% fetal calf serum (FCS), 100 U/ml of penicillin/streptomycin, 50 mg/ml of ascorbic acid and 2 mM sodium b-glycerophosphate] with or without (controls) 100 lg of HERS-CM proteins. Cells were collected after 21 days in culture (media were changed every other day), the media were removed, cells were rinsed in phosphate-buffered saline (PBS) and total RNA was extracted for determination of phenotype by using reverse transcriptionpolymerase chain reaction (RTPCR). AP, alkaline phosphatase; BMP-4, bone morphogenetic protein-4; BSP, bone sialoprotein; Col1, collagen type I; OCN, osteocalcin; OPN, osteopontin; OSN, osteonectin.
208
(Fig. 2). This effect is specic for periodontal ligament cells because other types of broblasts, such as those derived from the dental pulp, do not produce a mineralized extracellular matrix, even in the presence of HERS-CM. When cementoblast cells, capable of producing a mineralized extracellular matrix, were grown in the presence of HERS-CM, an acceleration in the formation of mineral was detected. Analysis of the phenotype at the molecular level indicated a de novo induction of the expression of bone sialoprotein and osteocalcin, two markers of mineralization (Fig. 3). These results support the concept that, during root development, the secreted products of the Hertwigs epithelial root sheath induce adjacent cells of the periodontal ligament to differentiate and produce new cementum. However, whether these cells differentiate into cementoblasts or osteoblasts awaits further in vivo experiments.
References
1. Adams DF. Diagnosis and treatment of refractory periodontitis. Curr Opin Dent 1992: 2: 3338. 2. Akizuki T, Oda S, Komaki M, Tsuchioka H, Kawakatsu N, Kikuchi A, Yamato MJ, Okano T, Ishikawa I. Application of periodontal ligament cell sheet for periodontal regeneration: a pilot study in beagle dogs. J Periodontal Res 2005: 40: 245251. 3. Alvarez-Perez MA, Narayanan S, Zeichner-David M, Rodriguez Carmona B, Arzate H. Molecular cloning, expression and immunolocalization of a novel human cementum-derived protein (CP-23). Bone 2006: 38: 409 419. 4. Amar S, Chung KM, Nam SH, Karatzas S, Myokai F, Van Dyke TE. Markers of bone and cementum formation accumulate in tissues regenerated in periodontal defects treated with expanded polytetrauoroethylene membranes. J Periodontal Res 1997: 32: 148158. 5. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999: 14: 529535. 6. Anusaksathien O, Webb SA, Jin QM, Giannobile WV Platelet-derived growth factor gene delivery stimulates ex vivo gingival repair. Tissue Eng 2003: 9: 745756. 7. Anusaksathien O, Jin Q, Zhao M, Somerman MJ, Giannobile WV. Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissueengineered cementum. J Periodontol 2004: 75: 429440. 8. Arweiler NB, Auschill TM, Donos N, Sculean A. Antibacterial effect of an enamel matrix protein derivative on in vivo dental biolm vitality. Clin Oral Invest 2002: 6: 205 209. 9. Arzate H, Portilla-Robertson J, Aguilar-Mendoza ME. Recombination of epithelial root sheath and dental papilla cells in vitro. Arch Med Res 1996: 27: 573577. 10. Atkinson ME. The development of the mouse molar periodontium. J Periodontal Res 1972: 7: 255260. 11. BarKana I, Narayanan AS, Grosskop A, Savion N, Pitaru S. Cementum attachment protein enriches putative cementoblastic populations on root surfaces in vitro. J Dent Res 2000: 79: 14821488. 12. Bartold PM, Narayanan AS, Page RC. Platelet-derived growth factor reduces the inhibitory effects of lipopolysaccharide on gingival broblast proliferation. J Periodontal Res 1992: 27: 499505. 13. Beertsen W, McCulloch CAG, Sodek J. The periodontal ligament: a unique, multifunctional connective tissues. Periodontol 2000 1997: 13: 2040. 14. Berkovitz BK. Periodontal ligament: structural and clinical correlates. Dent Update 2004: 31: 4650. 15. Birek C, Heersche JN, Jez D, Brunette DM. Secretion of a bone resorbing factor by epithelial cells cultured from porcine rests of Malassez. J Periodontal Res 1983: 18: 7581. 16. Birkedal-Hansen H, Butler WT, Taylor RE. Proteins from the periodontium. characterization of the insoluble collagens of bovine cementum. Calcif Tiss Res 1977: 23: 3944. 17. Boabaid F, Gibson CW, Kuehl MA, Berry JE, Snead ML, Nociti FH Jr, Katchburian E, Somerman MJ. Leucine-rich amelogenin peptide: a candidate signaling molecule during cementogenesis. J Periodontol 2004: 75: 11261136.
Conclusions
It is obvious that major progress has occurred in the world of biology, medicine and dentistry in the past 30 years, and the management of periodontal disease has beneted from these advances. New knowledge about the etiology and pathogenesis of periodontitis, the relationship of the disease to systemic problems, and advances in genetics, molecular biology, cell biology and biomaterials, have opened the door for new regenerative techniques based upon the tissue engineering approach. Treatment of periodontal disease has evolved from just ghting bacteria to a combined effort to eliminate the offending microorganisms, to arrest the progression of tissue damage and to regenerate lost tissues. Although some of the regenerative techniques have been available for several years, and some have shown promising results, none of the techniques are without problems and none have proven to be 100% effective. Many of the regenerative approaches reviewed in this article are still under assessment and further research is needed to develop cell-based tissue strategies, perhaps using stem cells and biomaterials for delivery of these cells. New scaffold materials, which are being developed, are also needed to address some of the delivery issues (164). What may be concluded from the current status of periodontal regeneration is that, as many investigators have previously stated, there is not going to be one magic solution that can be used to treat all periodontal patients, but rather a combination of different approaches that can be adjusted to t the specic need of individual patients.
209
Zeichner-David
18. Borrell LN, Papapanou PN. Analytical epidemiology of periodontitis. J Clin Periodontol 2005: 32: 132158. 19. Bosshardt DD. Are cementoblasts a subpopulation of osteoblasts or a unique phenotype? J Dent Res 2005: 84: 390406. 20. Bosshardt DD, Nanci A. Immunodetection of enamel- and cementum-related (bone) proteins at the enamel-free area and cervical portion of the tooth in rat molars. J Bone Miner Res 1997: 12: 367379. 21. Bosshardt DD, Selvig KA. Dental cementum: the dynamic tissue covering the root. Periodontol 2000 1997: 13: 41 75. 22. Bosshardt DD, Sculean A, Windisch P, Pjetursson BE, Lang NP. Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodontal Res 2005: 40: 158167. 23. Boyan LA, Bhargava G, Nishimura F, Orman R, Price R, Terranova VP. Mitogenic and hemotactic responses of human periodontal ligament cells to the different isoforms of platelet-derived growth factor. J Dent Res 1994: 73: 1593 1600. 24. Brice GL, Sampson WJ, Sims MR. An ultrastructural evaluation of the relationship between epithelial rests of Malassez and orthodontic root resorption and repair in man. Aust Orthod J 1991: 12: 9094. 25. Bronckers ALJJ, Farach-Carson MC, Van Waveren E, Butler WT. Immunolocalization of osteopontin, osteocalcin and dentin sialoproteins during dental root formation and early cementogenesis in the rat. J Bone Mineral Res 1994: 9: 833 841. 26. Browne RM. The pathogenesis of odontogenic cysts: a review. J Oral Pathol 1975: 4: 3146. 27. Brunette DM. Mechanical stretching increases the number of epithelial cells synthesizing DNA in culture. J Cell Sci 1984: 69: 3545. 28. Bunyaratavej P, Wang HL. Collagen membranes: a review. J Periodontol 2001: 72: 215229. 29. Caffesse RG, Holden MJ, Kon S, Nasjleti CE. The effect of citric acid and bronectin application on healing following surgical treatment of naturally occurring periodontal disease in beagle dogs. J Clin Periodontol 1985: 12: 578590. 30. Camelo M, Nevins ML, Schenk RK, Lynch SE, Nevins M. Periodontal regeneration in human Class II furcations using puried recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with bone allograft. Int J Periodontics Restorative Dent 2003: 23: 213225. 31. Caton JG, Quinones CR. Etiology of periodontal diseases. Curr Opin Dent 1991: 1: 1728. 32. Caton JG, DeFuria EL, Polson AM, Nyman S. Periodontal regeneration via selective cell repopulation. J Periodontol 1987: 58: 546552. 33. Cattaneo V, Rota C, Silvestri M, Piacentini C, Forlino A, Gallanti A, Rasperini G, Cetta G. Effect of enamel matrix derivative on human periodontal broblasts: proliferation, morphology and root surface colonization. An in vitro study. J Periodontal Res 2003: 38: 568574. 34. Chai Y, Jiang X, Ito Y, Bringas P, Han J, Rowitch DH, Soriano P, McMahon AP, Sucov HM. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 2000: 127: 16711679. 35. Chano L, Tenenbaum HC, Lekic PC, Sodek J, McCulloch CA. Emdogain regulation of cellular differentiation in wounded rat periodontium. J Periodontal Res 2003: 38: 164174. Cho MI, Lin WL, Genco RJ. Platelet-derived growth factorsmodulated guided tissue regenerative therapy. J Periodontol 1995: 66: 522530. Cochran DL, Wozney JM. Biological mediators for periodontal regeneration. Periodontol 2000 1999: 19: 4058. DErrico JA, Macneil RL, Takata T, Berry J, Strayhorn C, Somerman MJ. Expression of bone associated markers by tooth root lining cells, in situ and in vitro. Bone 1997: 20: 117 126. DSouza RN, Cavender A, Sood R, Tarnuzzer R, Dickinson DP, Roberts A, Letterio J. Dental abnormalities in mice lacking a functional transforming factor-beta 1 (TGF-b1) gene indicate a role for TGF-b1 in biomineralization. Int J Oral Biol 1998: 23: 119131. Dassule HR, Lewis P, Bei M, Maas R, McMahon AP. Sonic hedgehog regulates growth and morphogenesis of the tooth. Development 2000: 127: 47754785. Davenport DR, Mailhot JM, Wataha JC, Billman MA, Sharawy MM, Shrout MK. Effects of enamel matrix protein application on the viability, proliferation, and attachment of human periodontal ligament broblasts to diseased root surfaces in vitro. J Clin Periodontol 2003: 30: 125131. Davideau JL, Sahlberg C, Blin C, Papagerakis P, Thesleff I, Berdal A. Differential expression of the full-length and secreted truncated forms of EGF receptor during formation of dental tissues. Int J Dev Biol 1995: 39: 605615. De Obarrio JJ, Arauz-Dutari JI, Chamberlain TM, Croston A. The use of autologous growth factors in periodontal surgical therapy: platelet gel biotechnology case reports. Int J Periodontics Restorative Dent 2000: 20: 486497. Dennison DK, Vallone DR, Pinero GJ, Rittman B, Caffesse RG. Differential effect of TGF-beta 1 and PDGF on proliferation of periodontal ligament cells and gingival broblasts. J Periodontol 1994: 65: 641648. Diekwisch TG. The developmental biology of cementum. Int J Dev Biol 2001: 45: 695706. Diekwisch TG. Pathways and fate of migratory cells during late tooth organogenesis. Connect Tissue Res 2002: 43: 245 56. Esposito M, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev 2003: CD003875. Feng F, Hou LT. Treatment of osseous defects with broblast-coated hydroxylapatite particles. J Formos Med Assoc 1992: 91: 10681074. Feng F, Liu CM, Hsu WC, Hou LT. Long-term effects of gingival broblast-coated hydroxylapatite graft on periodontal osseous defects. J Formos Med Assoc 1995: 94: 494 498. Fetner AE, Hartigan MS, Low SB. Periodontal repair using PerioGlas in nonhuman primates: clinical and histologic observations. Compendium. 1994: 15: 935938. Fong HK, Foster BL, Popowics TE, Somerman MJ. The crowning achievement: getting to the root of the problem. J Dent Educ 2005: 69: 555570. Fowler EB, Breault LG, Cuenin MF. Periodontal disease and its association with systemic disease. Mil Med 2001: 166: 8589.
36.
37. 38.
39.
40.
41.
42.
43.
44.
45. 46.
47.
48.
49.
50.
51.
52.
210
211
Zeichner-David
89. Hoang AM, Oates TW, Cochran DL. In vitro wound healing responses to enamel matrix derivative. J Periodontol 2000: 71: 12701277. 90. Hoang AM, Klebe RJ, Steffensen B, Ryu OH, Simmer JP, Cochran DL. Amelogenin is a cell adhesion protein. J Dent Res 2002: 81: 497500. 91. Hou LT, Tsai AY, Liu CM, Feng F. Autologous transplantation of gingival broblast-like cells and a hydroxylapatite complex graft in the treatment of periodontal osseous defects: cell cultivation and long-term report of cases. Cell Transplant 2003: 12: 787797. 92. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human plateletderived growth factor-BB and recombinant human insulinlike growth factor-I in patients with periodontal disease. J Periodontol 1997: 68: 11861193. 93. Huang KK, Shen C, Chiang CY, Hsieh YD, Fu EJ. Effects of bone morphogenetic protein-6 on periodontal wound healing in a fenestration defect of rats. J Periodontal Res 2005: 40: 110. 94. Igarashi R, Sahara T, Shimizu-Ishiura M, Sasaki T. Porcine enamel matrix derivative enhances the formation of reparative dentine and dentine bridges during wound healing of amputated rat molars. J Electron Microsc 2003: 52: 227236. 95. Inoue M, LeGeros RZ, Hoffman C, Diamond K, Rosenberg PA, Craig RG. Effect of enamel matrix proteins on the phenotype expression of periodontal ligament cells cultured on dental materials. J Biomed Mater Res 2004: 69A: 172179. 96. Ishizaki NT, Matsumoto K, Kimura Y, Wang X, Yamashita A. Histopathological study of dental pulp tissue capped with enamel matrix derivative. J Endod 2003: 29: 176179. 97. Ivanovski S, Li H, Haase HR, Bartold PM. Expression of bone associated macromolecules by gingival and periodontal ligament broblasts. J Periodontal Res 2001: 36: 131141. 98. Iwata T, Morotome Y, Tanabe T, Fukae M, Ishikawa I, Oida S. Noggin blocks osteoinductive activity of porcine enamel extracts. J Dent Res 2002: 81: 387391. 99. Jepsen S, Eberhard J, Herrera D, Needleman I. A systematic review of guided tissue regeneration for periodontal furcation defects. What is the effect of guided tissue regeneration compared with surgical debridement in the treatment of furcation defects? J Clin Periodontol 2002: 29: 103116. 100. Jernvall J, Thesleff I. Reiterative signaling and patterning during mammalian tooth morphogenesis. Mech Dev 2000: 92: 1929. 101. Jiang J, Safavi KE, Spangberg LS, Zhu Q. Enamel matrix derivative prolongs primary osteoblast growth. J Endod 2001: 27: 110112. 102. Jiang J, Fouad AF, Safavi KE, Spangberg LS, Zhu Q. Effects of enamel matrix derivative on gene expression of primary osteoblasts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001: 91: 95100. 103. Jin QM, Anusaksathien O, Webb SA, Rutherford RB, Giannobile WV. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol 2003: 74: 202213. 104. Jin Q, Anusaksathien O, Webb SA, Printz MA, Giannobile WV. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 2004: 9: 519526. 105. Kagayama M, Sasano Y, Zhu JX, Hirata M, Mizohuchi I, Kamakura S. Epithelial rest colocalize with cementoblasts forming acellular cementum but not with cementoblasts forming cellular cementum. Acta Anat 1998: 163: 19. 106. Kalajzic I, Braut A, Guo D, Jiang X, Kronenberg MS, Mina M, Harris MA, Harris SE, Rowe DW. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone 2004: 35: 7482. 107. Kalpidis CD, Ruben MP. Treatment of intrabony periodontal defects with enamel matrix derivative: a literature review. J Periodontol 2002: 73: 13601376. 108. Kaneko H, Hashimoto S, Enokiya Y, Ogiuchi H, Shimono M. Cell proliferation and death of Hertwigs epithelial root sheath in the rat. Cell Tissue Res 1999: 298: 95103. 109. Karatzas S, Zavras A, Greenspan D, Amar S. Histologic observations of periodontal wound healing after treatment with PerioGlas in nonhuman primates. Int J Periodontics Restorative Dent 1999: 19: 489499. 110. Karlan MS, Hench LL, Madden M, Ogino M. A bonebonding bioactive material implant in the head and neck: bioglass. Surg Forum 1978: 29: 575577. 111. Kawaguchi H, Hirachi A, Hasegawa N, Iwata T, Hamaguchi H, Shiba H, Takata T, Kato Y, Kurihara H. Enhancement of periodontal tissue regeneration by transplantation of bone marrow mesenchymal stem cells. J Periodontol 2004: 75: 12811287. 112. Kawase T, Okuda K, Yoshie H, Burns DM. Cytostatic action of enamel matrix derivative (EMDOGAIN) on human oral squamous cell carcinoma-derived SCC25 epithelial cells. J Periodontal Res 2000: 35: 291300. 113. Kawase T, Okuda K, Momose M, Kato Y, Yoshie H, Burns DM. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and broblastic human cells. J Periodontal Res 2001: 36: 367 376. 114. Kawase T, Okuda K, Yoshie H, Burns DM. Anti-TGF-beta antibody blocks enamel matrix derivative-induced upregulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation. J Periodontal Res 2002: 37: 255262. 115. Keila S, Nemcovsky CE, Moses O, Artzi Z, Weinreb M. In vitro Effects of Enamel Matrix Proteins on Rat Bone Marrow Cells and Gingival Fibroblasts. J Dent Res 2004: 83: 134138. 116. King GN. New regenerative technologies: rationale and potential for periodontal regeneration: 2. Growth factors. Dent Update 2001: 28: 6065. 117. King GN. New regenerative technologies: rationale and potential for periodontal regeneration: 1. New advances in established regenerative strategies. Dent Update 2001: 28: 712. 118. King GN, Cochran DL. Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: a critical review. J Periodontol 2002: 73: 925936. 119. King GN, Hughes FJ. Bone morphogenetic protein-2 stimulates cell recruitment and cementogenesis during early wound healing. J Clin Periodontol 2001: 28: 465475. 120. King GN, King N, Cruchley AT, Wozney JM, Hughes FJ. Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects. J Dent Res 1997: 76: 14601470.
212
213
Zeichner-David
glycosaminoglycans by periodontal ligament broblasts in vitro. Dev Biol 1983: 97: 146153. Metzger Z, Weinstock B, Dotan M, Narayanan AS, Pitaru S. Differential chemotactic effect of cementum attachment protein on periodontal cells. J Periodontal Res 1998: 33: 126129. Miki Y, Narayanan AS, Page RC. Mitogenic activity of cementum components to gingival broblasts. J Dent Res 1987: 66: 13991403. Miletich I, Sharpe PT. Neural crest contribution to mammalian tooth formation. Birth Defects Res C Embryo Today 2004: 72: 200212. Miller N, Penaud J, Foliguet B, Membre H, Ambrosini P, Plombas M. Resorption rates of 2 commercially available bioresorbable membranes. A histomorphometric study in a rabbit model. J Clin Periodontol 1996: 23: 10511059. Mirastschijski U, Konrad D, Lundberg E, Lyngstadaas SP, Jorgensen LN, Agren MS. Effects of a topical enamel matrix derivative on skin wound healing. Wound Repair Regen 2004: 12: 100108. Mizutani S, Tsuboi T, Tazoe M, Koshihara Y, Goto S, Togari A. Involvement of FGF-2 in the action of Emdogain on normal human osteoblastic activity. Oral Dis 2003: 9: 210 217. Morsczeck C, Gotz W, Schierholz J, Zeilhofer F, Kuhn U, Mohl C, Sippel C, Hoffmann KH. Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol 2005: 24: 155165. Murphy KG, Gunsolley JC. Guided tissue regeneration for the treatment of periodontal intrabony and furcation defects. A systematic review. Ann Periodontol 2003: 8: 266 302. Murphy WL, Mooney DJ. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J Periodontal Res 1999: 34: 413419. Nabers CL, Pfeifer JS, Raust GT Jr, Ross SJ. What is the place of bone grafts in periodontal therapy? Periodontal Abstr 1967: 5: 149153. Nagano T, Iwata T, Ogata Y, Tanabe T, Gomi K, Fukae M, Arai T, Oida S. Effect of heat treatment on bioactivities of enamel matrix derivatives in human periodontal ligament(HPDL) cells. J Periodontal Res 2004: 39: 249256. Nakae H, Narayanan S, Raines E, Page RC. Isolation and partial characterization of mitogenic factors from cementum. Biochemistry 1991: 30: 70477052. Nakamura Y, Hammarstrom L, Lundberg E, Ekdahl H, Matsumoto K, Gestrelius S, Lyngstadaas SP. Enamel matrix derivative promotes reparative processes in the dental pulp. Adv Dent Res 2001: 15: 105107. Nakamura Y, Hammarstrom L, Matsumoto K, Lyngstadaas SP. The induction of reparative dentine by enamel proteins. Int Endod J 2002: 35: 407417. Nakashima M, Reddi AH. The application of bone morphogenetic proteins to dental tissue engineering. Nat Biotechnol 2003: 21: 10251032. Nevins M, Camelo M, Nevins ML, Schenk RK, Lynch SE. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J Periodontol 2003: 74: 12821292. Newman SA, Coscia SA, Jotwani R, Iacono VJ, Cutler CW. Effects of enamel matrix derivative on Porphyromonas gingivalis. J Periodontol 2003: 74: 11911195. 173. Nishimura K, Hayahi M, Matsuda K, Shigeyama Y, Yamasaki A, Yamaoka A. The chemoattractive potency of periodontal ligament, cementum and dentin for human gingival broblasts. J Periodontal Res 1989: 24: 146148. 174. Nyman S, Gottlow J, Karring T, Lindhe J. The regenerative potential of the periodontal ligament. An experimental study in the monkey. J Clin Periodontol 1982: 9: 257265. 175. Oates TW, Rouse CA, Cochran DL. Mitogenic effects of growth factors on human periodontal ligament cells in vitro. J Periodontol 1993: 64: 142148. 176. Ohshima M, Nishiyama T, Tokunaga K, Sato S, Maeno M, Otsuka K. Proles of cytokine expression in radicular cystlining epithelium examined by RT-PCR. J Oral Sci 2000: 42: 239246. 177. Ohyama M, Suzuki N, Yamaguchi Y, Maeno M, Otsuka K, Ito K. Effect of enamel matrix derivative on the differentiation of C2C12 cells. J Periodontol 2002: 73: 543550. 178. Okubo K, Kobayashi M, Takiguchi T, Takada T, Ohazama A, Okamatsu Y, Hasegawa K. Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells. J Periodontal Res 2003: 38: 19. 179. Okuda K, Momose M, Miyazaki A, Murata M, Yokoyama S, Yonezawa Y, Wolff LF, Yoshie H. Enamel matrix derivative in the treatment of human intrabony osseous defects. J Periodontol 2000: 71: 18211828. 180. Okuda K, Kawase T, Momose M, Murata M, Saito Y, Suzuki H, Wolff LF, Yoshie H. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol 2003: 74: 849857. 181. Orban B. The epithelial network in the periodontal membrane. J Am Dent Assoc 1952: 44: 632635. 182. Owens PDA. Ultrastructure of Hertwigs epithelial root sheath during early root development in premolar teeth in dogs. Arch Oral Biol 1978: 23: 91104. 183. Owens PDA. A light and electron microscopic study of early stages of root surface formation in molar teeth in the rat. Arch oral Biol 1980: 24: 901907. 184. Palioto DB, Coletta RD, Graner E, Joly JC, de Lima AF. The inuence of enamel matrix derivative associated with insulin-like growth factor-I on periodontal ligament broblasts. J Periodontol 2004: 75: 498504. 185. Palmer RM, Lubbock MJ. The soft connective tissues of the gingiva and periodontal ligament: are they unique? Oral Dis 1995: 1: 230237. 186. Palmer RM, Lumsden AG. Development of periodontal ligament and alveolar bone in homografted recombinations of enamel organs and papillary, pulpal, and follicular mesenchyme in the mouse. Arch Oral Biol 1987: 32: 281 289. 187. Parashis A, Tsiklakis K. Clinical and radiographic ndings following application of enamel matrix derivative in the treatment of intrabony defects. A series of case reports. J Clin Periodontol 2000: 27: 705713. 188. Park JB, Matsuura M, Han KY, Norderyd O, Lin WL, Genco RJ. Periodontal regeneration in class III furcation defects in beagle dogs using guided tissue regenerative therapy with platelet-derived growth factor. J Periodontol 1995: 66: 462 477.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.
171.
172.
214
215
Zeichner-David
220. Sculean A, Auschill TM, Donos N, Brecx M, Arweiler NB. Effect of an enamel matrix protein derivative (Emdogain) on ex vivo dental plaque vitality. J Clin Periodontol 2001: 28: 10741078. 221. Sculean A, Windisch P, Keglevich T, Gera I. Clinical and histologic evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restorative Dent 2005: 25: 139147. 222. Selvig KA. Electron microscopy of Hertwigs epithelial sheath and of early dentin and cementum formation in the mouse incisor. Acta Odontol Scand 1963: 21: 175186. 223. Sena K, Morotome Y, Baba O, Terashima T, Takano Y, Ishikawa I. Gene expression of growth differentiation factors in the developing periodontium of rat molars. J Dent Res 2003: 82: 166171. 224. Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, Brahim J, Young M, Robey PG, Wang CY, Shi S. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004: 364: 149155. 225. Seo BM, Miura M, Sonoyama W, Coppe C, Stanyon R, Shi S. Recovery of stem cells from cryopreserved periodontal ligament. J Dent Res 2005: 84: 907912. 226. Shear M, Pindborg JJ. Microscopic features of the lateral periodontal cyst. Scand J Dent Res 1975: 83: 103110. 227. Shimizu E, Nakajima Y, Kato N, Nakayama Y, Saito R, Samoto H, Ogata Y. Regulation of rat bone sialoprotein gene transcription by enamel matrix derivative. J Periodontol 2004: 75: 260267. 228. Shimizu E, Saito R, Nakayama Y, Nakajima Y, Kato N, Takai H, Kim DS, Arai M, Simmer J, Ogata Y. Amelogenin stimulates bone sialoprotein (BSP) expression through broblast growth factor 2 response element and transforming growth factor-beta1 activation element in the promoter of the BSP gene. J Periodontol 2005: 76: 14821489. 229. Shimizu-Ishiura M, Tanaka S, Lee WS, Debari K, Sasaki T. Effects of enamel matrix derivative to titanium implantation in rat femurs. J Biomed Mater Res 2002: 60: 269276. 230. Shroff B, Kashner JE, Keyser JD, Hebert C, Norris K Epidermal growth factor and epidermal growth factor-receptor expression in the mouse dental follicle during tooth eruption. Arch Oral Biol 1996: 41: 613617. 231. Silvestri M, Rasperini G, Euwe E. Enamel matrix derivative in treatment of infrabony defects. Pract Periodontics Aesthet Dent 1999: 11: 615616. 232. Slavkin HC. Towards a cellular and molecular understanding of periodontics: cementogenesis revisited. J Periodontol 1976: 47: 249255. 233. Slavkin HC, Boyd A. Cementum: an epithelial secretory product? J Dent Res 1974: 53: 157. 234. Slavkin HC, Bringas P, Bessem C, Santos V, Nakamura M, Hsu M, Snead ML, Zeichner-David M, Fincham AG. Hertwigs epithelial root sheath differentiation and initial cementum and bone formation during long-term organ culture of mouse mandibular rst molars using serumless, chemically-dened medium. J Periodontal Res 1988: 23: 2840. 235. Slavkin HC, Bessem C, Fincham AG, Bringas P, Santos V, Snead ML, Zeichner-David M. Human and mouse cementum proteins immunologically related to enamel proteins. Biochim Biophys Acta 1989: 991: 1218. 236. Somerman MJ, Perez-Mera M, Merkhofer RM, Foster RA. In vitro evaluation of extracts of mineralized tissues for their application in attachment of brous tissue. J Periodontol 1987: 58: 349351. 237. Spahr A, Lyngstadaas SP, Boeckh C, Andersson C, Podbielski A, Haller B. Effect of the enamel matrix derivative Emdogain on the growth of periodontal pathogens in vitro. J Clin Periodontol 2002: 29: 6272. 238. Spouge JD. A new look at the rests of Malassez: a review of their embryological origin, anatomy, and possible role in periodontal health and disease. J Periodontol 1980: 51: 437444. 239. Steele-Perkins G, Butz KG, Lyons GE, Zeichner-David M, Kim HJ, Cho MI, Gronostajski RM. Essential role for NFI-C/ CTF transcription-replication factor in tooth root development. Mol Cell Biol 2003: 23: 10751084. 240. Sykaras N, Opperman LA. Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician? J Oral Sci 2003: 45: 5773. 241. Talic NF, Evans CA, Daniel JC, Zaki AE. Proliferation of epithelial rests of Malassez during experimental tooth movement. Am J Orthod Dentofacial Orthop 2003: 123: 527533. 242. Tatemoto Y, Okada Y, Mori M. Squamous odontogenic tumor: immunohistochemical identication of keratins. Oral Surg Oral Med Oral Pathol 1989: 67: 6367. 243. Ten Cate AR. A ne structural study of coronal and root dentinogenesis in the mouse. Observations of the so called von korff bers and their contribution to mantle dentine. J Anat 1978: 125: 183197. 244. Ten Cate AR. The role of epithelium in the development, structure and function of the tissues of tooth support. Oral Dis 1996: 2: 5562. 245. Ten Cate AR, Mills C. The development of the periodontium: the origin of alveolar bone. Anat Rec 1972: 173: 6978. 246. Tenorio D, Cruchley A, Hughes FJ. Immunocytochemical investigation of the rat cementoblast phenotype. J Periodontal Res 1993: 28: 411419. 247. Terranova VP. Periodontal and bone regeneration factor, materials and methods. International patent # WO 90/ 100017. 1990. 248. Terranova VP, Wikesjo UM. Extracellular matrices and polypeptide growth factors as mediators of functions of cells of the periodontium. J Periodontol 1987: 58: 371380. 249. Thesleff I. Developmental biology and building a tooth. Quintessence Int 2003: 34: 613620. 250. Thomadakis G, Ramoshebi LN, Crooks J, Rueger DC, Ripamonti U. Immunolocalization of Bone Morphogenetic Protein-2 and -3 and Osteogenic Protein-1 during murine tooth root morphogenesis and in other craniofacial structures. Eur J Oral Sci 1999: 107: 368377. 251. Thomas HF. Root formation. Int J Dev Biol 1995: 39: 231237. 252. Thomas HF, Kollar EJ. Differentiation of odontoblasts in grafted recombinants of murine epithelial root sheath and dental mesenchyme. Arch Oral Biol 1989: 34: 2735. 253. Thomas BL, Tucker AS, Qui M, Ferguson CA, Hardcastle Z, Rubenstein JL, Sharpe P. Role of Dlx-1 and Dlx-2 genes in patterning of the murine dentition. Development 1997: 124: 48114818. 254. Tokiyasu Y, Takata T, Saygin E, Somerman M. Enamel factors regulate expression of genes associated with cementoblasts. J Periodontol 2000: 71: 18291839.
216
268.
269.
270. 271.
272. 273.
274.
275.
276.
277.
278.
279.
280.
217